Prostate cancer is the second-leading cause of cancer death in American men. About 1 in 8 men will be diagnosed with prostate cancer in their lifetime, and the risk varies depending on age and race.

PSA testing is a key tool in detecting prostate issues early, but interpreting results requires context. Levels can rise from cancer or other benign conditions, so follow-up tests are often needed.

Despite the common nature of this disease, the United States Preventative Services Task Force (USPSTF) recently published a recommendation that men should not seek PSA testing. Disputes regarding the ...

NEW YORK (Reuters Health) - Giving men decision-making tools to help them consider the pros and cons of prostate cancer screening changed how they valued different possible outcomes but did not affect ...